Ford patent could lock out owners for missed payment, repossessed remotely – TheBlaze
New Ford patent for a new technological system that would allow the automaker to lock out owners from their cars for missed payments.
Archive for March, 2023
-
In: PATENT NEWS
-
In: TRADEMARK NEWS
OED Appointment Request – United States Patent and Trademark Office
OED Appointment Request United States Patent and Trademark Office
-
In: PATENT NEWS
GUEST VIEW: Big companies’ latest attack on the little guy – Yahoo News
… their patents, some large companies find it more economical . … companies use the Patent Trial and Appeal Board, an administrative law body …
-
In: PATENT NEWS
What exam do lawyers take. “I want to testify. 617-495-1880. P…
It is also known as the patent bar exam or patent exam. … Once you’ve earned your bachelor’s degree, you can take the law school admission test …
-
In: COPYRIGHT NEWS
AI and its implications for copyright -opinion – The Jerusalem Post
AI and its implications for copyright -opinion The Jerusalem Post
-
In: PATENT NEWS
The Ford Patent That Could Put Your Car in the Junkyard – Torque News
As it turns out, those days may end with a new patent idea by Ford that will probably become a reality…and a legal mess: a Ford patent that allows …
-
In: PATENT NEWS
Career Ladder: Kerisha Bowen – C&EN
Pivot to patents. After considering her options, Bowen decided to enroll in a master’s program in patent law at the University of Notre Dame. She didn …
-
In: PATENT NEWS
Ford Patents Technology Against Its Delinquent Customers: If You Don’t Pay, The Car Will …
Ford Motor Patents in a technology that allows the application to remotely … a senior attorney with the National Center for Consumer Law.
-
In: PATENT NEWS
Ford files for patent to remotely repossess cars for missing payments – WCPO
Automaker Ford has filed for a patent on technology that would allow it to remotely take control of vehicles to repossess them for payment issues.
-
In: PATENT NEWS
Medytox’s BTX patent could face invalidation trial in US – The Investor
Medytox’s BTX patent could face invalidation trial in US The Investor